Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by JohnEnglishon Mar 20, 2015 7:49am
57 Views
Post# 23542050

RE:RE:RE:RE:RE:RE:15

RE:RE:RE:RE:RE:RE:15You're free to believe whatever you want. As I said earlier I've never had a Stockhouse account before this and this is the only one I have.

Please, link to where I stated I've made 2 or 3 accounts previously. Oh that's right you can't because I never said that. You've gone from suggesting that I have other accounts to now saying that I admitted to it which is incorrect.. 

It's unfortunate that you're resorting to deliberately spreading misinformation to push your own agenda which I assume is to push the stock higher. I base this assumption on the fact that you keep instsing that I'm trying to push the stock lower simply becuase I've quoted from that M|Partners note a few times and mentioned that the validation studies were being comducted prior to Phase 2 trials.

You can make all the accusations you want but without actually backing them up with anything other than wild speculation or deliberate misinformation it's plainly obvious that you're pushing an agenda. By not directly addressing my requests to link to posts where I've supposedly made certain claims you are admitting that you are wrong as you cannot back up any of these statements.

I'm sure you'll ignore this post just like all the others and will instead just continue to make baseless accusations without anything to back them.
Bullboard Posts